DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $1.6M
- Closes
- Nov 12, 2026 (in 61 days)
Similar opportunities open now
- DoW Vision, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 61 days
- DoW Vision, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 61 days
- DoW Arthritis Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 40 days
- DoW Spinal Cord Injury, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 61 days
- DoW Toxic Exposures Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 68 days
Classification and identifiers
- Solicitation number
- HT942526VRPTRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $1.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial , but not a full-scale clinical trial . Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · If developing new drugs or device(s), the research team must include expertise in the regulatory approval process. · The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering ...